Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All Patients of RA of age 18 years or more who are managed with methotrexate for = one year
Exclusion criteria
Exclusion criteria: Patient already having thyroid disease at the time of diagnosis of rheumatoid arthritis Pregnant patients Patient on drugs affecting thyroid function Patients undergone surgery or radiation around neck area Patient having any hypothalamo-pituitary disorder/disease Patients not willing to give consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To estimate the proportion of patients with altered thyroid profiles among the patients of Rheumatoid arthritis who were taking methotrexate for = 1 yearTimepoint: duration of study is 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the association of thyroid profile with different durations of methotrexate use. To evaluate the association of thyroid profile with different add on drugs in Rheumatoid arthritis management. To examine the Adverse Drug Reaction arising from anti-rheumatoid drug treatment Timepoint: duration of study is 1 year | — |
Countries
India
Contacts
AIIMS Rishikesh